We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
Cap. Flow
+$6.04B
Cap. Flow %
4.61%
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 8.26%
2 Financials 3.77%
3 Consumer Discretionary 2.12%
4 Communication Services 1.89%
5 Healthcare 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCT icon
3201
GigaCloud Technology
GCT
$1.35B
$279K ﹤0.01%
+9,833
New +$256K
TMFS icon
3202
Motley Fool Small-Cap Growth ETF
TMFS
$57.8M
$279K ﹤0.01%
8,086
-200
-2% -$7.03K
VRDN icon
3203
Viridian Therapeutics
VRDN
$2.13B
$279K ﹤0.01%
12,918
+110
+0.9% +$1.98K
SPB icon
3204
Spectrum Brands
SPB
$2.04B
$279K ﹤0.01%
+5,306
New +$294K
NRIM icon
3205
Northrim BanCorp
NRIM
$603M
$278K ﹤0.01%
12,831
+447
+4% +$10.1K
FBP icon
3206
First Bancorp
FBP
$4.4B
$278K ﹤0.01%
+12,588
New +$272K
IBHE
3207
DELISTED
iShares iBonds 2025 Term High Yield and Income ETF
IBHE
$277K ﹤0.01%
11,944
-124
-1% -$2.88K
PAGP icon
3208
Plains GP Holdings
PAGP
$5.23B
$277K ﹤0.01%
15,192
+742
+5% +$14.2K
ZEUS
3209
DELISTED
Olympic Steel
ZEUS
$277K ﹤0.01%
9,092
-1,117
-11% -$36.6K
CIM
3210
Chimera Investment
CIM
$1.05B
$277K ﹤0.01%
20,941
-825
-4% -$11.5K
SH icon
3211
ProShares Short S&P500
SH
$887M
$277K ﹤0.01%
+7,482
New +$289K
SNDX icon
3212
Syndax Pharmaceuticals
SNDX
$1.84B
$276K ﹤0.01%
17,970
+2,526
+16% +$33.1K
QURE icon
3213
uniQure
QURE
$2.68B
$276K ﹤0.01%
+4,735
New +$86K
EMO
3214
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
$275K ﹤0.01%
+6,115
New +$288K
SPGM icon
3215
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.7B
$275K ﹤0.01%
+3,666
New +$263K
OR icon
3216
OR Royalties Inc
OR
$5.47B
$274K ﹤0.01%
+6,827
New +$213K
ENOV icon
3217
Enovis
ENOV
$1.56B
$274K ﹤0.01%
+9,015
New +$273K
SPRY icon
3218
ARS Pharmaceuticals
SPRY
$590M
$273K ﹤0.01%
27,175
-10,429
-28% -$150K
MOO icon
3219
VanEck Agribusiness ETF
MOO
$989M
$273K ﹤0.01%
+3,716
New +$275K
IBDV icon
3220
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.25B
$273K ﹤0.01%
12,312
-1,301
-10% -$28.6K
PFLD icon
3221
AAM Low Duration Preferred and Income Securities ETF
PFLD
$415M
$272K ﹤0.01%
13,800
-3,000
-18% -$58.9K
VICR icon
3222
Vicor
VICR
$9.62B
$272K ﹤0.01%
5,465
+281
+5% +$13.7K
CGDG icon
3223
Capital Group Dividend Growers ETF
CGDG
$5.38B
$272K ﹤0.01%
+7,836
New +$267K
DX
3224
Dynex Capital
DX
$2.99B
$271K ﹤0.01%
22,075
+3,409
+18% +$42.7K
AGYS icon
3225
Agilysys
AGYS
$2.78B
$270K ﹤0.01%
+2,570
New +$284K

Similar funds

Creative Planning's Q3 2025 Portfolio in Review

As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.

  • Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
  • Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
  • Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
  • Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
  • Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
  • Creative Planning opened 364 new positions and closed 133 in Q3 2025.
  • Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.